Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Signifor (pasireotide)
i
Other names:
SOM230
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Recordati
Drug class:
SSTR agonist
Related drugs:
‹
lanreotide prolonged-release subcutaneous (2)
DG3173 (1)
octreotide subcutaneous depot (0)
octreotide extended release (0)
vapreotide (0)
pasireotide long acting release (0)
Debio 4126 (0)
octreotide acetate (0)
octreotide acetate solution for injection (0)
MTD201 (0)
lanreotide prolonged-release subcutaneous (2)
DG3173 (1)
octreotide subcutaneous depot (0)
octreotide extended release (0)
vapreotide (0)
pasireotide long acting release (0)
Debio 4126 (0)
octreotide acetate (0)
octreotide acetate solution for injection (0)
MTD201 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF wild-type + NRAS wild-type
Melanoma
BRAF wild-type + NRAS wild-type
Melanoma
pasireotide
Sensitive: C3 – Early Trials
pasireotide
Sensitive
:
C3
pasireotide
Sensitive: C3 – Early Trials
pasireotide
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.